Uncategorized

Network News, News, Press Releases, Uncategorized

John Theurer Cancer Center Investigators Report Poor Colorectal Cancer Biomarker Testing Rates

Less than half of patients with metastatic tumors have the recommended genomic profiling that forms the basis of precision oncology

Investigators at John Theurer Cancer Center (JTCC) at Hackensack University Medical Center in New Jersey are the first to report poor adherence to genomic profiling guidelines for four biomarkers of metastatic colorectal cancer used to predict response to therapy,

Network News, Press Releases, Uncategorized

John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma

Triple-drug regimen shown to be superior to conventional treatment in major multicenter study presented at American Society of Hematology annual meeting

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey were part of the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma.